Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia
Arturo Pereira, Alberto Álvarez‐Larrán(Hospital Clínic de Barcelona), Francisca Ferrer‐Marín(Centre for Biomedical Network Research on Rare Diseases), Francisco Cervantes(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Eduardo Arellano‐Rodrigo(Vall d'Hebron Hospital Universitari), Manuel Pérez‐Encinas(Complejo Hospitalario Universitario de Santiago), Valentín García‐Gutiérrez(Universidad de Alcalá), Pere Barba(Universitat Autònoma de Barcelona), Ana Kerguelen(Hospital Universitario La Paz), Elena Magro(Hospital Universitario de Gran Canaria Doctor Negrín), José-Ramón González-Porras(Hospital General Universitario Morales Meseguer), Natàlia Estrada(Hospital Universitari Germans Trias i Pujol), Juan Carlos Hernández‐Boluda(Hospital Clínico Universitario de Valencia), Rosa Ayala(Hospital Universitario 12 De Octubre), M.J. Moreno(Hospital Universitario La Paz), Montse Gómez(Hospital Clínico Universitario de Valencia), María-Isabel Mata(Hospital Costa del Sol), Carles Besses(Hospital Del Mar)
Cited by 54
Related Papers
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
|New England Journal of Medicine|2021|532
Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs
|Journal of Clinical Oncology|2012|461
Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma
|Blood|2014|429